Angelika Fretzen is a Pioneer at Artis Ventures. She serves on the Executive Team at the Wyss Institute for Biologically Inspired Engineering at Harvard University as the Technology Translation Director. Previously, she was the SVP of Product Development at Catabasis Pharmaceuticals and VP of Pharmaceutical Chemistry & Development at Ironwood Pharmaceuticals. As a Pioneer, Angelika brings pharma R&D experience as well as technical chemistry expertise.
Angelika Fretzen, PhD